Source news

globenewswire News

20 stories
globenewswire

Arbor Realty Trust Declares Preferred Stock Dividends

UNIONDALE, N.Y., June 29, 2026 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. NYSE:ABR, today announced that its Board of Directors has declared cash dividends on the Company's Series D, Series E, and Series F cumulative redeemable preferred stock of $0.3984375, $0.390625, and $0.390625 per share, re…

GlobeNewswire en
ETFsStocksUS
globenewswire

GMEX Robotics Corporation Announces Share Consolidation

SYDNEY, Australia, June 29, 2026 (GLOBE NEWSWIRE) -- GMEX Robotics Corporation NASDAQ:GMEX (the “Company”), today announced that it will effect a share consolidation of (i) its issued and unissued existing Class A ordinary shares, par value of $0.0896 per share, at a ratio of 1-for-9, with a post-s…

GlobeNewswire en
StocksUS
globenewswire

RGC Resources, Inc. Declares Quarterly Dividend

ROANOKE, Va., June 29, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of RGC Resources, Inc. NASDAQ:RGCO declared a quarterly dividend of $0.2175 per share on the Company’s common stock. The dividend will be paid on August 3, 2026 to shareholders of record on July 17, 2026. This is the Company’s 3…

GlobeNewswire en
StocksUS
globenewswire

Dime Continues Support for Sunrise Day Camp

HAUPPAUGE, N.Y., June 29, 2026 (GLOBE NEWSWIRE) -- Dime Commercial Bancshares, Inc. (the “Company” or “Dime”) NYSE:DCOM, announced today that it continued to support the annual fundraising event Sunrise Walk-A-Thon that benefits children with cancer and their siblings who attend Sunrise Day Camp.AB…

GlobeNewswire en
StocksUS
globenewswire

Mama’s Creations. Announces Proposed Public Offering of Common Stock

EAST RUTHERFORD, New Jersey, June 29, 2026 (GLOBE NEWSWIRE) -- Mama’s Creations, Inc. (“Mama’s Creations” or the “Company”) NASDAQ:MAMA, a leading national marketer and manufacturer of fresh deli prepared foods, today announced the commencement of a proposed, underwritten public offering of shares…

GlobeNewswire en
StocksUS
globenewswire

Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies

FDA sets updated PDUFA date of December 27, 2026BOSTON, June 29, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. NASDAQ:PRAX, a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that the U.S. Food and Drug Administrati…

GlobeNewswire en
StocksUS
globenewswire

Publication relating to transparency notifications

REGULATED INFORMATIONPublication relating to transparency notificationsMont-Saint-Guibert (Belgium), June 29, 2026, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Law of May 2, 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/NASDAQ:NYXH announces that i…

GlobeNewswire en
StocksBE
globenewswire

DHT Holdings, Inc. Announces Fleet Upgrades and Charter Management

HAMILTON, BERMUDA, June 29, 2026 – DHT Holdings, Inc. NYSE:DHT (“DHT” or the “Company”) today announced that it has identified and will implement a proactive design upgrade for its two newbuildings delivering from Hyundai this year. The upgrades are intended to ensure optimal trading eligibility an…

GlobeNewswire en
globenewswire

Pathfinder Bancorp, Inc. Declares Dividend

OSWEGO, N.Y., June 29, 2026 (GLOBE NEWSWIRE) -- James A. Dowd, President and CEO of Pathfinder Bancorp, Inc., the bank holding company of Pathfinder Bank NASDAQ:PBHC listing:PathBcp), has announced that the Company has declared a cash dividend of $0.10 per share on the Company's voting common and n…

GlobeNewswire en
StocksUS
globenewswire

Norwegian Cruise Line Names Lee Applbaum as Chief Marketing Officer

Applbaum Brings More Than 25 Years of Experience Building Iconic Global Brands, Leading High-Performing Teams and Driving Strong CultureNORWEGIAN CRUISE LINE NAMES LEE D. APPLBAUM AS CHIEF MARKETING OFFICERMIAMI, June 29, 2026 (GLOBE NEWSWIRE) -- Norwegian Cruise Line®, the innovator in global crui…

GlobeNewswire en
StocksUS
globenewswire

Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival

Company AnnouncementCOPENHAGEN, Denmark; June 29, 2026 – Genmab A/S NASDAQ:GMAB today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of fixed duration epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, and lenalidomide, compar…

GlobeNewswire en
StocksDK